A Review of the Benefits of Satureja Species on Metabolic Syndrome and Their Possible Mechanisms of Action

Journal of Evidence-Based Complementary and Alternative Medicine

Volumn 20, Issue 3, 2015, Pages 212-223

  Babajafari, Siavash ^a   Nikaein, Farzad ^b   Mazloomi, Seyed Mohammad ^a   Zibaeenejad, Mohammad Javad ^c   Zargaran, Arman ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

medicinal herb; metabolic syndrome; Satureja

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; PLANT EXTRACT;

ANIMAL; CELL LINE; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; RAT; SAVORY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL LINE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MALE; METABOLIC SYNDROME X; PLANT EXTRACTS; RATS; SATUREJA;

EID: 84930579215     PISSN: 21565872     EISSN: None     Source Type: Journal    
DOI: 10.1177/2156587214564188     Document Type: Review

References (132)

1. James PT,Rigby N,Leach R.The obesity epidemic, metabolic syndrome and future prevention strategies.Eur J Cardiovasc Prev Rehabil. 2004;11:3-8
2. Nabipour I,Amiri M,Imami SR, et al.The metabolic syndrome and nonfatal ischemic heart disease: a population-based study.Int J Cardiol. 2007;118:48-53
3. Reaven GM.Banting Lecture 1988. Role of insulin resistance in human disease.Diabetes. 1988;37:1595-1607
4. Consensus Development Conference on Insulin Resistance; November 5-6, 1997.Diabetes Care. 1998;21:310-314
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA. 2001;285:2486-2497
6. Magkos F,Yannakoulia M,Chan JL,Mantzoros CS.Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.Annu Rev Nutr. 2009;29:223-256
7. Kastorini CM,Milionis HJ,Esposito K,Giugliano D,Goudevenos JA,Panagiotakos DB.The effect of Mediterranean diet on metabolic syndrome and its components a meta-analysis of 50 studies and 534,906 individuals.J Am Coll Cardiol. 2011;57:1299-1313
8. Panagiotakos DB,Chrysohoou C,Pitsavos C, et al.The association of Mediterranean diet with lower risk of acute coronary syndromes in hypertensive subjects.Int J Cardiol. 2002;82:141-147
9. Azadbakht L,Mirmiran P,Esmaillzadeh A,Azizi T,Azizi F.Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome.Diabetes Care. 2005;28:2823-2831
10. Christ M,Iannello C,Iannello PG,Grimm W.Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome.Int J Cardiol. 2004;97:115-122
11. Orchard TJ,Temprosa M,Goldberg R, et al.The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.Ann Intern Med. 2005;142:611-619
12. Gerstein HC,Yusuf S,Pogue J, et al.Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.Lancet. 2006;368:1096-1105
13. Ballantyne CM,Olsson AG,Cook TJ,Mercuri MF,Pedersen TR,Kjekshus J.Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.Circulation. 2001;104:3046-3051
14. Pyorala K,Ballantyne CM,Gumbiner B, et al.Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).Diabetes Care. 2004;27:1735-1740
15. Deedwania P,Barter P,Carmena R, et al.Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.Lancet. 2006;368:919-928
16. Yusuf S,Sleight P,Pogue J,Bosch J,Davies R,Dagenais G.Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.N Engl J Med. 2000;342:145-153
17. Yusuf S,Teo K,Anderson C, et al.Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.Lancet. 2008;372:1174-1183
18. Park IW,Sheen SS,Yoon D, et al.Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?.J Clin Pharm Ther. 2014;39:61-68
19. Molnar MZ,Kalantar-Zadeh K,Lott EH, et al.Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.J Am Coll Cardiol. 2013;63:650-658
20. Olson EA,Hainsworth DP,Davis G,Hagan JC.Eye on statins: a comprehensive review.Mo Med. 2013;110:344-348
21. Cusi K,DeFronzo RA.Metformin: a review of its metabolic effects.Diabetes Rev. 1998;6:89-131
22. Stein SA,Lamos EM,Davis SN.A review of the efficacy and safety of oral antidiabetic drugs.Expert Opin Drug Saf. 2013;12:153-175
23. Kung J,Henry RR.Thiazolidinedione safety.Expert Opin Drug Saf. 2012;11:565-579
24. Madar Z,Abel R,Samish S,Arad J.Glucose-lowering effect of fenugreek in non-insulin dependent diabetics.Eur J Clin Nutr. 1988;42:51-54
25. Joseph B,Jini D.Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency.Asian Pac J Trop Dis. 2013;3:93-102
26. Khan A,Khattak KN,Safdar M,Anderson RA,Ali Khan MM.Cinnamon improves glucose and lipids of people with type 2 diabetes.Diabetes Care. 2003;26:3215-3218
27. Mang B,Wolters M,Schmitt B, et al.Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2.Eur J Clin Invest. 2006;36:340-344
28. Crawford P.Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial.J Am Board Fam Med. 2009;22:507-512
29. Hajhashemi V,Abbasi N.Hypolipidemic activity of Anethum graveolens in rats.Phytother Res. 2008;22:372-375
30. Brankovic S,Radenkovic M,Kitic D, et al.Comparison of the hypotensive and bradycardic activity of ginkgo, garlic, and onion extracts.Clin Exp Hypertens. 2011;33:95-99
31. Lee YJ,Choi DH,Kim EJ, et al.Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet.Am J Chin Med. 2011;39:39-52
32. Hopkins AL,Lamm MG,Funk JL,Ritenbaugh C.Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies.Fitoterapia. 2013;85:84-94
33. Hadian J,Tabatabaei SMF,Naghavi MR,Jamzad Z,Ramak-Masoumi R.Genetic diversity of Iranian accessions of Satureja hortensis L. based on horticultural traits and RAPD markers.Sci Hortic. 2008;115:196-202
34. Skoula M,Grayer RJ,Kite GC.Surface flavonoids in Satureja thymbra and Satureja spinosa (Lamiaceae).Biochem Syst Ecol. 2005;33:541-544
35. Saeidnia S,Nourbakhsh MS,Gohari AR,Davood A.Isolation and identification of the main compounds of Satureja sahendica Bornm.Aust J Basic Appl Sci. 2011;5:1450-1453
36. Darbour N,Baltassat F,Raynaud J,Pellecuer J.Flavonoid glycosides in leaves of Satureja hortensis L. (Labiatae).Pharm Acta Helv. 1990;65:239-240
37. Gora J,Lis A,Lewandowski A.Chemical composition of the essential oil of cultivated summer savory (Satureja hortensis L. cv. Saturn).J Essent Oil Res. 1996;8:427-428
38. Leung AY,Foster S.Encyclopaedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: Wiley; 1996:465–466.New York, NY: Wiley; 1996:465-466.
39. Piras A,Cocco V,Falconieri D, et al.Isolation of the volatile oil from Satureja thymbra by supercritical carbon dioxide extraction: chemical composition and biological activity.Nat Prod Commun. 2011;6:1523-1526
40. Madsen HL,Andersen L,Christiansen L,Brockhoff P,Bertelsen G.Antioxidative activity of summer savory (Satureja hortensis L.) and rosemary (Rosmarinus officinalis L.) in minced, cooked pork meat.Z Lebensm Unters Forch. 1996;203:333-338
41. Dorman HJD,Hiltunen R.Fe(III) reductive and free radical-scavenging properties of summer savory (Satureja hortensis L.) extract and subfractions.Food Chem. 2004;88:193-199
42. Abdollahi M,Salehnia A,Mortazavi SH, et al.Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of essential oil of Saturejakhuzestanica in rat in vivo: an oxicopharmacological study.Med Sci Monit. 2003;9:BR331-BR335
43. Rezvanfar MA,Farshid AA,Sadrkhanlou RA, et al.Benefit of Satureja khuzestanica in subchronically rat model of cyclophosphamide-induced hemorrhagic cystitis.Exp Toxicol Pathol. 2010;62:323-330
44. Vosough-Ghanbari S,Rahimi R,Kharabaf S, et al.Effects of Saturejakhuzestanica on serum glucose, lipids and markers of oxidative stress in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.Evid Based Complement Alternat Med. 2010;7:465-470
45. Gutierrez RMP,Navarro YTG.Antioxidant and hepatoprotective effects of the methanol extract of the leaves of Saturejamacrostema.Pharmacogn Mag. 2010;6:125-131
46. Kaeidi A,Esmaeili-Mahani S,Abbasnejad M, et al.Satureja khuzestanica attenuates apoptosis in hyperglycemic PC12 cells and spinal cord of diabetic rats.J Nat Med. 2013;67:61-69
47. Shahsavari R,Ehsani-Zonouz A,Houshmand M,Salehnia A,Ahangari G,Firoozrai M.Plasma glucose lowering effect of the wild Saturejakhuzestanica Jamzad essential oil in diabetic rats: role of decreased gluconeogenesis.Pak J Biol Sci. 2009;12:140-145
48. Basiri S,Esmaily H,Vosough-Ghanbari S,Mohammadirad A,Yasa N,Abdollahi M.Improvement by Satureja khuzestanica essential oil of malathion-induced red blood cells acetylcholinesterase inhibition and altered hepatic mitochondrial glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities.Pestic Biochem Physiol. 2007;89:124-129
49. Öztürk M.Anticholinesterase and antioxidant activities of Savoury (Saturejathymbra L.) with identified major terpenes of the essential oil.Food Chem. 2012;134:48-54
50. Prieto JM,Iacopini P,Cioni P,Chericoni S.In vitro activity of the essential oils of Origanum vulgare, SaturejaMontana and their main constituents in peroxynitrite-induced oxidative processes.Food Chem. 2007;104:889-895
51. Ghazanfari G,Minaie B,Yasa N, et al.Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica Jamzad essential oil on the mouse model of inflammatory bowel diseases.Toxicol Mech Methods. 2006;16:365-372
52. Hajhashemi V,Ghannadi A,Pezeshkian SK.Antinociceptive and anti-inflammatory effects of Satureja hortensis L. extracts and essential oil.J Ethnopharmacol. 2002;82:83-87
53. Amanlou M,Dadkhah F,Salehnia A,Farsam H,Dehpour AR.An anti-inflammatory and anti-nociceptive effects of hydroalcoholic extract of Satureja khuzistanica Jamzad extract.J Pharm Pharm Sci. 2005;8:102-106
54. Sabzghabaee AM,Davoodi N,Ebadian B,Aslani A,Ghannadi A.Clinical evaluation of the essential oil of Satureja hortensis for the treatment of denture stomatitis.Dent Res J. 2012;9:198-202
55. Suárez A,Echandi MM,Ulate G,Cicció JF.Pharmacological activity of the essential oil of Satureja viminea (Lamiaceae).Rev Biol Trop. 2003;51:247-252
56. Cetojević-Simin DD,Canadanović-Brunet JM,Bogdanović GM,Cetković GS,Tumbas VT,Djilas SM.Antioxidative and antiproliferative effects of Satureja montana L. extracts.J BUON. 2004;9:443-449
57. Gohari AR,Ostad SN,Moradi-Afrapoli F, et al.Evaluation of the cytotoxicity of Satureja spicigera and its main compounds.Scientific World Journal. 2012;2012:203861
58. Hajhashemi V,Sadraei H,Ghannadi AR,Mohseni M.Antispasmodic and anti-diarrhoeal effect of Satureja hortensis L. essential oil.J Ethnopharmacol. 2000;71:187-192
59. de Rojas VRS,Somoza B,Ortega T,Villar AM,Tejerina T.Vasodilatory effect in rat aorta of eriodictyol obtained from Satureja obovata.Planta Med. 1999;65:234-238
60. Gulluce M,Sokmen M,Daferera D, et al.In vitro antibacterial, antifungal, and antioxidant activities of the essential oil and methanol extracts of herbal parts and callus cultures of Satureja hortensis L.J Agric Food Chem. 2003;51:3958-3965
61. Deans SG,Svoboda KP.Antibacterial activity of summer savory (Satureja hortensis L.) essential oil.J Horticult Sci. 1989;64:205-210
62. Sahin F,Karaman I,Gulluce M, et al.Evaluation of antimicrobial activities of Satureja hortensis L.J Ethnopharmacol. 2003;87:61-65
63. Abad MJ,Bermejo P,Gonzales E,Iglesias I,Irurzun A,Carrasco L.Antiviral activity of Bolivian plant extracts.Gen Pharmacol. 1999;32:499-503
64. Yazdanparast R,Shahriyary L.Comparative effects of Artemisia dracunculus, Satureja hortensis and Origanum majorana on inhibition of blood platelet adhesion, aggregation and secretion.Vascul Pharmacol. 2008;48:32-37
65. Bagheri S,Ahmadvand H,Khosrowbeygi A, et al.Antioxidant properties and inhibitory effects of Satureja khozestanica essential oil on LDL oxidation induced-CuSO4 in vitro.Asian Pac J Trop Biomed. 2013;3:22-27
66. Boone CW,Kelloff GJ,Malone WE.Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.Cancer Res. 1990;50:2-9
67. Ceppi ED,Titheradge MA.The importance of nitric oxide in the cytokine-induced inhibition of glucose formation by cultured hepatocytes incubated with insulin, dexamethasone, and glucagon.Arch Biochem Biophys. 1998;349:167-174
68. Ceriello A.Oxidative stress and glycemic regulation.Metabolism. 2000;49 (2 suppl 1): 27-29
69. Waltner-Law ME,Daniels MC,Sutherland C,Granner DK.NF-κB inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene.J Biol Chem. 2000;275:31847-31856
70. Waltner-Law ME,Wang XL,Law BK,Hall RK,Nawano M,Granner DK.Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production.J Biol Chem. 2002;277:34933-34940
71. Tandogan B,Kuruüzüm-Uz A,Sengezer C,Güvenalp Z,Demirezer LÖ,Ulusu NN.In vitro effects of rosmarinic acid on glutathione reductase and glucose 6-phosphate dehydrogenase.Pharm Biol. 2011;49:587-594
72. Saadat M,Pournourmohammadi S,Donyavi M, et al.Alteration of rat hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities by Satureja khuzestanica Jamzad essential oil.J Pharm Pharm Sci. 2004;7:310-314
73. Ahmadvand H,Tavafi M.Hepatoprotective and hypolipidemic effects of Satureja khuzestanica essential oil in alloxan-induced type 1 diabetic rats.Iran J Pharm Res. 2012;11:1219-1226
74. Case GL,He L,Mo H,Elson CE.Induction of geranyl pyrophosphate pyrophosphatase activity by cholesterol-suppressive isoprenoids.Lipids. 1995;30:357-359
75. Yang RL,Shi YH,Hao G,Li W,Le GW.Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index.J Clin Biochem Nutr. 2008;43:154-158
76. Takahashi N,Kawada T,Goto T, et al.Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3-L1 adipocytes and HepG2 hepatocytes.FEBS Lett. 2002;514:315-322
77. Tontonoz P,Hu E,Spiegelman BM.Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor.Cell. 1994;79:1147-1156
78. Lehmann JM,Moore LB,Smith-Oliver TA,Wilkison WO,Willson TM,Kliewer SA.An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ).J Biol Chem. 1995;270:12953-12956
79. Willson TM,Cobb JE,Cowan DJ, et al.The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.J Med Chem. 1996;39:665-668
80. Hsu MH,Savas Ü,Griffin KJ,Johnson EF.Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor α in hepg2 cells.J Biol Chem. 2001;276:27950-27958
81. Staels B,Dallongeville J,Auwerx J,Schoonjans K,Leitersdorf E,Fruchart JC.Mechanism of action of fibrates on lipid and lipoprotein metabolism.Circulation. 1998;98:2088-2093
82. Peters JM,Hennuyer N,Staels B, et al.Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice.J Biol Chem. 1997;272:27307-27312
83. Aeschbach R,Loliger J,Scott BC, et al.Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol.Food Chem Toxicol. 1994;32:31-36
84. Takahashi Y,Inaba N,Kuwahara S,Kuki W.Antioxidative effect of citrus essential oil components on human low-density lipoprotein in vitro.Biosci Biotechnol Biochem. 2003;67:195-197
85. Teissedre PL,Waterhouse AL.Inhibition of oxidation of human low-density lipoproteins by phenolic substances in different essential oils varieties.J Agric Food Chem. 2000;48:3801-3805
86. Lee KG,Shibamoto T.Inhibition of malonaldehyde formation from blood plasma oxidation by aroma extracts and aroma components isolated from clove and eucalyptus.Food Chem Toxicol. 2001;39:1199-1204
87. Balavoine GG,Gelettii YV.Peroxynitrite scavenging by different antioxidants. Part I: convenient assay.Nitric Oxide. 1999;3:40-54
88. Virag L,Szabo E,Gergely P,Szabo C.Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention.Toxicol Lett. 2003;140-141:113-124
89. Stewart AJ,Del Rio D,Pellegrini N.A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.Nutr Metab Cardiovasc Dis. 2005;15:316-328
90. Mohiuddin I,Chai H,Lin PH,Lumsden AB,Yao Q,Chen C.Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system.J Surg Res. 2006;133:143-149
91. Ha H,Hwang IA,Park JH,Lee HB.Role of reactive oxygen species in the pathogenesis of diabetic nephropathy.Diabetes Res Clin Pract. 2008;82 (suppl 1): S42-S45
92. Monaco C,Andreakos E,Kiriakidis S, et al.Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.Proc Natl Acad Sci U S A. 2004;101:5634-5639
93. Abdollahi M,Chan TS,Subrahmanyam V,O’Brien PJ.Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to amitochondrial toxin.Mol Cell Biochem. 2003;252:205-211
94. Abdollahi M,Bahreini-Moghadam A,Emami B,Fooladian F,Zafari K.Increasing intracellular cAMP and cGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva.Comp Biochem Physiol C Toxicol Pharmacol. 2003;135C:331-336
95. Abdollahi M,Fooladian F,Emami B,Zafari K,Bahreini-Moghadam A.Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva.Hum Exp Toxicol. 2003;22:587-592
96. Khoshakhlagh P,Bahrololoumi-Shapourabadi M,Mohammadirad A,Ashtaral-Nakhai L,Minaie B,Abdollahi M.Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress.Toxicol Mech Methods. 2007;17:281-288
97. Ranjbar A,Ghahremani MH,Sharifzadeh M, et al.Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain.Hum Exp Toxicol. 2010;29:851-864
98. Radfar M,Larijani B,Hadjibabaie M,Rajabipour B,Mojtahedi A,Abdollahi M.Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double blind placebo-controlled clinical trial.Biomed Pharmacother. 2005;59:302-306
99. Milani E,Nikfar S,Khorasani R,Zamani MJ,Abdollahi M.Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats.Comp Biochem Physiol C Toxicol Pharmacol. 2005;140:251-255
100. Chae MK,Park SG,Song SO, et al.Pentoxifylline attenuates methionine-and choline-deficient-diet-induced steatohepatitis by suppressing TNF-α expression and endoplasmic reticulum stress.Exp Diabetes Res. 2012;2012:762565
101. Houslay MD,Adams DR.PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.Biochem J. 2003;370 (pt 1): 1-18
102. Clark IA.How TNF was recognized as a key mechanism of disease.Cytokine Growth Factor Rev. 2007;18:335-343
103. Calixto JB,Beirith A,Ferreira J,Santos AR,Cechinel Filho V,Yunes RA.Naturally occurring anti-nociceptive substances from plants.Phytother Res. 2000;14:401-418
104. Wang Y,Chen P,Tang C,Wang Y,Li Y,Zhang H.Antinociceptive and anti-inflammatory activities of extract and two isolated flavonoids of Carthamus tinctorius L.J Ethnopharmacol. 2014;151:944-950
105. Moghaddam FM,Farimani MM,Salahvarzi S,Amin G.Chemical constituents of dichloromethane extract of cultivated Satureja khuzistanica.Evid Based Complement Alternat Med. 2007;4:95-98
106. Park HH,Lee S,Oh JM, et al.Anti-inflammatory activity of fisetin in human mast cells (HMC-1).Pharmacol Res. 2007;55:31-37
107. Park HH,Lee S,Son HY, et al.Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells.Arch Pharm Res. 2008;31:1303-1311
108. Hotta M,Nakata R,Katsukawa M,Hori K,Takahashi S,Inoue H.Carvacrol, a component of thyme oil, activates PPAR α and γ, and suppresses COX-2 expression.J Lipid Res. 2010;51:132-139
109. Grande S,Bogani P,Saizieu AD,Schueler G,Galli C,Visioli F.Vasomodulating potential of Mediterranean wild plant extracts.J Agric Food Chem. 2004;52:5021-5026
110. Moncada S,Palmer RM,Higgs EA.NO physiology, pathophysiology and pharmacology.Pharmacol Rev. 1991;43:109-142
111. Radziszewski W,Chopra M,Zembowicz A,Gryglewski R,Ignarro LJ,Chaudhuri G.Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins.Int J Cardiol. 1995;51:211-220
112. Shiina Y,Funabashi N,Lee K, et al.Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults.Int J Cardiol. 2009;131:424-429
113. Saadali B,Boriky D,Blaghen M,Vanhaelen M,Talbi M.Alkamides from Artemisia dracunculus.Phytochemistry. 2001;58:1083-1086
114. Engelmeier D,Hadacek F,Hofer O, et al.Antifungal 3-butylisocoumarins from Asteraceae–Anthemideae.J Nat Prod. 2004;67:19-25
115. Bijak M,Ponczek MB,Nowak P.Polyphenol compounds belonging to flavonoids inhibit activity of coagulation factor X.Int J Biol Macromol. 2014;65C:129-135
116. Mekhfi H,Haouari ME,Legssyer A, et al.Platelet anti-aggregant property of some Moroccan medicinal plants.J Ethnopharmacol. 2004;94:317-322
117. Elliott Middleton JR,Chithan K,Theoharis CT.The effects of plants flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.Pharmacol Rev. 2000;52:673-751
118. Hoult JRS,Paya M.Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential.Gen Pharmacol. 1996;27:713-722
119. Vinten-Johansen J,Sato H,Zhao ZQ.The role of nitric oxide and NO-donor agents in myocardial protection from surgical ischemic-reperfusion injury.Int J Cardiol. 1995;50:273-281
120. Zheng W,Wang SY.Antioxidant activity and phenolic compounds in selected herbs.J Agric Food Chem. 2001;49:5165-5170
121. Craig JW.Health-promoting properties of common herbs.Am J Clin Nutr. 1999;70 (3 suppl): S491-S499
122. Tapsell LC,Hemphill I,Cobiac L, et al.Health benefits of herbs and spices: the past, the present, the future.Med J Aust. 2006;185 (4 suppl): S4-S24
123. Zargaran A,Zarshenas MM,Karimi A,Yarmohammadi H,Borhani-Haghighi A.Management of stroke as described by Ibn Sina (Avicenna) in the Canon of Medicine.Int J Cardiol. 2013;169:233-237
124. Pradhan AD,Ridker PM.Do atherosclerosis and type 2 diabetes share a common inflammatory basis?.Eur Heart J. 2002;23:831-834
125. Ramana KV,Srivastava S,Singhal SS.Lipid peroxidation products in human health and disease.Oxid Med Cell Longev. 2013;2013:583438
126. Guzik B,Sagan A,Ludew D, et al.Mechanisms of oxidative stress in human aortic aneurysms—association with clinical risk factors for atherosclerosis and disease severity.Int J Cardiol. 2013;168:2389-2396
127. Strobel NA,Fassett RG,Marsh SA,Coombes JS.Oxidative stress biomarkers as predictors of cardiovascular disease.Int J Cardiol. 2011;147:191-201
128. Di Francesco V,Zamboni M,Dioli A, et al.Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons.J Gerontol A Biol Sci Med Sci. 2005;60:1581-1585
129. Mosaffa F,Behravan J,Karimi G,Iranshahi M.Antigenotoxic effects of Satureja hortensis L. on rat lymphocytes exposed to oxidative stress.Arch Pharm Res. 2006;29:159-164
130. Ghalamkari G,Toghyani M,Tavalaeian E,Landy N,Ghalamkari Z,Radnezhad H.Efficiency of different levels of Satureja hortensis L.(Savory) in comparison with an antibiotic growth promoter on performance, carcass traits, immune responses and serum biochemical parameters in broiler chickens.Afr J Biotechnol. 2011;10:13318-13323
131. Masuda H,Mori N,Hirooka S, et al.Effects of winter savory (Satureja montana L.) on peripheral body temperature of people who experience a “feeling of cold” (Hie-Sho).Food Sci Technol Res. 2011;17:429-436
132. Tavafi M,Ahmadvand H,Tamjidipoor A,Delfan B,Khalatbari AR.Satureja khozestanica essential oil ameliorates progression of diabetic nephropathy in uninephrectomized diabetic rats.Tissue Cell. 2011;43:45-51